Pauling David (CIK 2063633) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-06). Recent activity: Buy STRO (675 shares), Sell STRO (277 shares), Buy STRO (500 shares), Buy STRO (842 shares), Sell STRO (551 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Buy | 675 | $0 |
| 2026-03-06 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Sell | 277 | $5,903 |
| 2026-03-03 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Buy | 500 | $0 |
| 2026-03-03 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Buy | 842 | $0 |
| 2026-03-03 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Sell | 551 | $11,279 |
| 2026-03-03 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Buy | 2,356 | $0 |
| 2026-03-03 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Sell | 970 | $19,934 |
| 2025-10-16 | SUTRO BIOPHARMA, INC. (STRO) | Chief Admin. Ofcr. & GC | Buy | 12,504 | $0 |
Source: SEC Form 4 filings · as of 2026-03-06